Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Stellantis N.V. Common Shares (STLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Stellantis N.V. Common Shares — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B), while Stellantis N.V. Common Shares trades at $4.27 (market cap $16.20B). The key difference: Stellantis N.V. Common Shares is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Stellantis N.V. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.
| KYMR | STLA | |
|---|---|---|
Market Cap | $8.88B | $16.20B |
Volume | 1,028,790 | 30,607,418 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $12.12 |
52-Week Low | $55.80 | $4.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.27B | $35.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Stellantis N.V. Common Shares
Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →
